Corbion NV (CRBN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Corbion NV (CRBN) has a cash flow conversion efficiency ratio of 0.155x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€115.20 Million ≈ $134.68 Million USD) by net assets (€742.60 Million ≈ $868.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Corbion NV to measure how much of total assets are equity-financed.
Corbion NV - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Corbion NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Corbion NV's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Corbion NV Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Corbion NV ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
O-I Glass Inc
NYSE:OI
|
-0.205x |
|
HHC Changzhou Corp.
SHE:301061
|
N/A |
|
Huafon Microfibre Shanghai Co
SHE:300180
|
0.029x |
|
Guangzhou Restaurants Group Co
SHG:603043
|
0.243x |
|
Avanos Medical Inc
NYSE:AVNS
|
-0.016x |
|
RLJ Lodging Trust
NYSE:RLJ
|
0.029x |
|
Xiangtan Electrochemical Scientific Co Ltd
SHE:002125
|
0.034x |
|
Lufax Holding Ltd
NYSE:LU
|
0.022x |
Annual Cash Flow Conversion Efficiency for Corbion NV (2002–2025)
The table below shows the annual cash flow conversion efficiency of Corbion NV from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see Corbion NV market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €742.60 Million ≈ $868.18 Million |
€160.90 Million ≈ $188.11 Million |
0.217x | -9.08% |
| 2024-12-31 | €772.50 Million ≈ $903.13 Million |
€184.10 Million ≈ $215.23 Million |
0.238x | -8.33% |
| 2023-12-31 | €636.20 Million ≈ $743.78 Million |
€165.40 Million ≈ $193.37 Million |
0.260x | +205.77% |
| 2022-12-31 | €625.70 Million ≈ $731.51 Million |
€53.20 Million ≈ $62.20 Million |
0.085x | +76.45% |
| 2021-12-31 | €554.10 Million ≈ $647.80 Million |
€26.70 Million ≈ $31.22 Million |
0.048x | -78.07% |
| 2020-12-31 | €516.00 Million ≈ $603.26 Million |
€113.40 Million ≈ $132.58 Million |
0.220x | +0.50% |
| 2019-12-31 | €529.10 Million ≈ $618.57 Million |
€115.70 Million ≈ $135.27 Million |
0.219x | +14.33% |
| 2018-12-31 | €520.20 Million ≈ $608.17 Million |
€99.50 Million ≈ $116.33 Million |
0.191x | -20.48% |
| 2017-12-31 | €489.30 Million ≈ $572.04 Million |
€117.70 Million ≈ $137.60 Million |
0.241x | -2.19% |
| 2016-12-31 | €498.50 Million ≈ $582.80 Million |
€122.60 Million ≈ $143.33 Million |
0.246x | +8.77% |
| 2015-12-31 | €487.80 Million ≈ $570.29 Million |
€110.30 Million ≈ $128.95 Million |
0.226x | +72.19% |
| 2014-12-31 | €508.70 Million ≈ $594.72 Million |
€66.80 Million ≈ $78.10 Million |
0.131x | +569.57% |
| 2013-12-31 | €504.80 Million ≈ $590.16 Million |
€9.90 Million ≈ $11.57 Million |
0.020x | -91.47% |
| 2012-12-31 | €858.70 Million ≈ $1.00 Billion |
€197.40 Million ≈ $230.78 Million |
0.230x | +47.30% |
| 2011-12-31 | €948.30 Million ≈ $1.11 Billion |
€148.00 Million ≈ $173.03 Million |
0.156x | -7.55% |
| 2010-12-31 | €1.12 Billion ≈ $1.31 Billion |
€188.60 Million ≈ $220.49 Million |
0.169x | -39.23% |
| 2009-12-31 | €997.80 Million ≈ $1.17 Billion |
€277.20 Million ≈ $324.08 Million |
0.278x | +165.57% |
| 2008-12-31 | €941.60 Million ≈ $1.10 Billion |
€98.50 Million ≈ $115.16 Million |
0.105x | -27.82% |
| 2007-12-31 | €957.70 Million ≈ $1.12 Billion |
€138.80 Million ≈ $162.27 Million |
0.145x | -31.13% |
| 2006-12-31 | €844.90 Million ≈ $987.78 Million |
€177.80 Million ≈ $207.87 Million |
0.210x | -76.09% |
| 2005-12-31 | €946.40 Million ≈ $1.11 Billion |
€833.00 Million ≈ $973.86 Million |
0.880x | +254.75% |
| 2004-12-31 | €806.50 Million ≈ $942.88 Million |
€200.10 Million ≈ $233.94 Million |
0.248x | -42.04% |
| 2003-12-31 | €778.10 Million ≈ $909.68 Million |
€333.10 Million ≈ $389.43 Million |
0.428x | +60.94% |
| 2002-12-31 | €739.10 Million ≈ $864.09 Million |
€196.60 Million ≈ $229.85 Million |
0.266x | -- |
About Corbion NV
Corbion N.V. provides lactic acid and derivatives, food preservation solutions, functional ingredient systems, and algae-derived nutritional ingredients in the Netherlands, the United States, Asia, rest of Americas, the rest of Europe, the Middle East, and Africa. It operates in two segments, Functional Ingredients & Solutions, and Health & Nutrition. The company offers antioxidants, fermentation… Read more